Pfizer Invests in Homology Medicines, Supporting Gene Therapies for PKU
News
Homology Medicines, which specializes in gene therapies for rare diseases and is developing two potential such therapies — HMI-102 and HMI-103 — for people with phenylketonuria (PKU), ... Read more